GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET
ConditionSubfertility
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexFemale
Age18-42
SponsorThe University of Hong Kong
About this trial
The objectives of this study are to compare the efficacy of the dual trigger group vs the hCG trigger group on the live birth rate in women undergoing IVF and the efficacy of the agonist in LP group vs the placebo group on the live birth rate in women undergoing FET.
Eligibility criteria
Qualifiers
None
Disqualifiers
Preimplantation genetic diagnosis treatment
Use of donor oocytes or donor embryos
Hydrosalpinx shown on pelvic scanning and not surgically treated
Women at risk of OHSS
Trial design
Treatments tested in this trial
- IVF: Decapeptyl and hCG
- FET: Decapeptyl
- IVF: hCG and normal saline
- FET: Normal Saline
Treatment groups
784 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov